OLcure Trio 40mg/10mg/12.5mg Tablet
By Olcure Trio
Rx
15 Tablet in a Strip

Composition
Olmesartan Medoxomil(40mg) + Cilnidipine(10mg) + Chlorthalidone(12.5mg)

Manufacturer - HBC Lifesciences Pvt Ltd
Office No: B,412-419, Atria-the business hub, Kh Road, Sargasan Cross Roads, S.G.Highway, Gandhinagar-382421., Gujarat, India.

Expires on or after
June, 2027

liver
OLcure Trio 40mg/10mg/12.5mg Tablet should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of OLcure Trio 40mg/10mg/12.5mg Tablet in such cases. It is advised to consult your doctor before taking this medication if you have liver issues. Please note that the use of OLcure Trio 40mg/10mg/12.5mg Tablet is not recommended for patients with severe liver disease.

kidney
OLcure Trio 40mg/10mg/12.5mg Tablet requires caution in severe kidney disease. Dose adjustment may be necessary, and it is advisable to consult a doctor. Avoid use in such patients.

alcohol
OLcure Trio 40mg/10mg/12.5mg Tablet can increase drowsiness when consumed with alcohol.

driving
OLcure Trio 40mg/10mg/12.5mg Tablet may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
OLcure Trio 40mg/10mg/12.5mg Tablet is not safe for use during pregnancy, as it poses a definite risk to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor.

breastfeeding
It is better to consult your doctor before using OLcure Trio 40mg/10mg/12.5mg Tablet.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | CARDIAC |
| Action Class | - |
₹242.76
₹285.6
15% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
